Pharmacrime is a multi-phase project aimed at improving the effectiveness of investigations on pharmaceutical crime. Pharmacrime aims to increase the capacities of enforcement and judicial authorities on issues related to falsified/counterfeit medicine investigations and encourage gradual compatibility of investigation approaches at European level. These projects are implemented by Eucojust aisbl, a Belgian not-for-profit international association, in partnership with several European authorities. Pharmacrime 1, 2 and 3 received financial support from the European Commission (DG Home).

 

Pharmacrime 1 (2010) focused on practical investigation cases and identification of good practice in the field of falsified medicines. A conference gathering 130 participants from EU and neighbouring countries was organised in Brussels in 2010. See here for more.

 

Pharmacrime 2 (2012) focused on the issues of falsified medicines sold over the internet. A practical guide for investigators was produced and presented at the occasion of a conference organised in Brussels in 2012. See here for more.

 

Pharmacrime 3 (2014) focused on investigations against criminal groups attempting to enter the legal supply chain. An expert workshop and a conference were organised in January and March 2014 (See here for more). A European Investigation Guide was produced and translated into 12 EU languages. See here for more.

 

Pharmacrime 4 (2014-2015) is ongoing. It focuses on raising awareness of European judges and prosecutors on recent legislations on falsified medicines and on the management of international investigations. See here for more.

 

Falsified medicines on the web. Click here to have access to to a selection of news and articles on falsified medicines.

 

The participation to Pharmacrime conferences was mentioned in an independent report assessing G8 commitments on measures against counterfeit medical products. See section "health" of the online report http://www.g7.utoronto.ca/evaluations/2012compliance/index.html